MF
AVNS

Manchester Financial’s Avanos Medical AVNS Stock Holding History

Manchester Financial’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-6
Closed – – 125
2021
Q1 		$0 Hold
6
– – ﹤0.01% 700
2020
Q4 		$0 Hold
6
– – ﹤0.01% 600
2020
Q3 		$0 Hold
6
– – ﹤0.01% 555
2020
Q2 		$0 Hold
6
– – ﹤0.01% 519
2020
Q1 		$0 Hold
6
– – ﹤0.01% 498
2019
Q4 		$0 Buy
+6
New +$217 ﹤0.01% 554
2019
Q3 		– Sell
-6
Closed – – 85
2019
Q2 		$0 Buy
+6
New +$257 ﹤0.01% 502

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Manchester Financial's AVNS Position: Q2 2021 in Review

Manchester Financial sold out of Avanos Medical (AVNS) in Q2 2021, closing a stake of 6 shares.

Manchester Financial first reported a position in AVNS in Q2 2019 and held it in 7 quarters. The position peaked at $0 in Q1 2021. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2021.

  • Manchester Financial reported no remaining Avanos Medical position as of Q2 2021 after selling out during the quarter.
  • Manchester Financial sold 6 Avanos Medical shares in Q2 2021.
  • Manchester Financial first reported a position in Avanos Medical in Q2 2019 and held it in 7 quarters.
  • Manchester Financial's Avanos Medical position peaked at $0 in Q1 2021.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2021.

Based on Manchester Financial's 13F filing for Q2 2021, filed 21 Jul 2021.